TELIX PHARMACEUTICALS LIMITED - Announcements

3.08%

$17.64

Market Cap $5.969B

Healthcare Biotechnology

Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on... Telix Pharmaceuticals Limited is an Australia-based biopharmaceutical company focused on the development and commercialization of therapeutic and diagnostic radiopharmaceuticals and associated medical technologies. It is developing a portfolio of clinical and commercial stage products that aims to address significant unmet medical needs in oncology and rare diseases. Its segments include Therapeutics, Precision Medicine and Telix Manufacturing Solutions. Therapeutics segment develops targeted radionuclide therapies for urologic, neurologic, musculoskeletal and hematological cancers. Precision Medicine segment focuses on bringing diagnostic imaging solutions to market. Precision Medicine segment also includes MedTech and International businesses. Telix Manufacturing Solutions segment is its global network of facilities designed to deliver patient doses worldwide. Its pipeline products include TLX591, TLX250, TLX101, TLX66, TLX592, TLX252, TLX400, Illuccix (68Ga-PSMA-11) and TLX007-CDx.More

Race Oncology (ASX: RAC) is an ASX-listed clinical stage biopharmaceutical company with a dedicated mission to be at the heart of cancer care. LATEST: Race Oncology Accelerates Game-Changing Cancer Drug.

Announcements

Filter Results

All Price Sensitive Only

TLX	Historical Financials in USD and H12025 OPEX (Unaudited)	PRICE SENSITIVE	05/08/25	473.82KB	Share
TLX	Telix H1 2025 Results - Investor Webcast Notification		30/07/25	189.18KB	Share
TLX	Pending Release of Shares from Voluntary Escrow		23/07/25	195.92KB	Share
TLX	Telix Reports US$204M Q2 Revenue, Up 63% YOY	PRICE SENSITIVE	22/07/25	282.97KB	Share
TLX	Gozellix Receives Permanent HCPCS Code	PRICE SENSITIVE	09/07/25	195.59KB	Share
TLX	Application for quotation of securities - TLX		09/07/25	18.9KB	Share
TLX	Notification of cessation of securities - TLX		09/07/25	14.32KB	Share
TLX	Application for quotation of securities - TLX		20/06/25	22.03KB	Share
TLX	App 3Y - Change in Director Interests - C Behrenbruch		18/06/25	324.58KB	Share
TLX	Notification regarding unquoted securities - TLX		18/06/25	20.67KB	Share
TLX	Telix Investor Day Presentation	PRICE SENSITIVE	11/06/25	7.51MB	Share
TLX	Notification regarding unquoted securities - TLX		05/06/25	15.2KB	Share
TLX	Application for quotation of securities - TLX		05/06/25	21.92KB	Share
TLX	Notification regarding unquoted securities - TLX		05/06/25	26.28KB	Share
TLX	Notification regarding unquoted securities - TLX		05/06/25	21.01KB	Share
TLX	App 3Z Final Director Interests - K McCann		22/05/25	182.21KB	Share
TLX	Telix Results of Annual General Meeting		21/05/25	230.02KB	Share
TLX	Telix Annual General Meeting Presentation		21/05/25	1.53MB	Share
TLX	Telix Annual General Meeting Chairman and CEO Addresses		21/05/25	236.93KB	Share
TLX	Pending Release of Shares from Voluntary Escrow		19/05/25	136.4KB	Share
TLX	Application for quotation of securities - TLX		16/05/25	19.37KB	Share
TLX	Notification regarding unquoted securities - TLX		16/05/25	18.58KB	Share
TLX	Notification of cessation of securities - TLX		16/05/25	13KB	Share
TLX	Notification regarding unquoted securities - TLX		09/05/25	16.43KB	Share
TLX	Cleansing Notice		06/05/25	114.02KB	Share
TLX	Application for quotation of securities - TLX		06/05/25	15.97KB	Share
TLX	App 3Z Final Director Interests - A Whitaker		01/05/25	181.61KB	Share
TLX	Anne Whitaker Board Resignation		29/04/25	126.07KB	Share
TLX	Telix Provides Regulatory Update on TLX101-CDx	PRICE SENSITIVE	28/04/25	140.77KB	Share
TLX	Pending Release of Shares from Voluntary Escrow		24/04/25	139.61KB	Share
TLX	Telix Reports US$186M Q1 Revenue, Up 62% YOY	PRICE SENSITIVE	22/04/25	214.9KB	Share
TLX	Pending Release of Shares from Voluntary Escrow		22/04/25	137.47KB	Share
TLX	Telix Notice of AGM, Proxy Form and Online Guide		17/04/25	3.33MB	Share
TLX	IPAX-Linz Promising Efficacy for TLX101 Glioma Tx Candidate		16/04/25	152.97KB	Share
TLX	Change of Registry Address Notification		14/04/25	67.5KB	Share
TLX	Telix Responds to Recent U.S. Government Actions		07/04/25	140.09KB	Share
TLX	App 3X Initial Director Interests - A Whitaker		04/04/25	230.84KB	Share
TLX	Anne Whitaker Appointed as Non-Executive Director		04/04/25	129.07KB	Share
TLX	Notification of cessation of securities - TLX		03/04/25	13.04KB	Share
TLX	Application for quotation of securities - TLX		03/04/25	22.2KB	Share
TLX	Pending Release of Shares from Voluntary Escrow		03/04/25	138.24KB	Share
TLX	Pending Release of Shares from Voluntary Escrow		03/04/25	137.35KB	Share
TLX	Change in substantial holding		02/04/25	467.97KB	Share
TLX	Pending Release of Shares from Voluntary Escrow		02/04/25	139.99KB	Share
TLX	Pending Release of Shares from Voluntary Escrow		25/03/25	136.43KB	Share
TLX	Application for quotation of securities - TLX		21/03/25	21.87KB	Share
TLX	FDA Approves New Prostate Cancer Imaging Agent Gozellix	PRICE SENSITIVE	21/03/25	144.27KB	Share
TLX	Illuccix Approved in Brazil - 1st PSMA-PET Approval in LATAM		18/03/25	189.55KB	Share
TLX	Cleansing Notice		17/03/25	112.99KB	Share
TLX	Application for quotation of securities - TLX		17/03/25	17.18KB	Share
TLX	Cleansing Notice		17/03/25	113.99KB	Share
TLX	Application for quotation of securities - TLX		17/03/25	15.98KB	Share
TLX	Notification of cessation of securities - TLX		12/03/25	13.69KB	Share
TLX	App 3Y Change of Director Interests - C Behrenbruch		12/03/25	280.44KB	Share
TLX	Telix Completes FAP-Targeting Theranostic Acquisition	PRICE SENSITIVE	12/03/25	135.5KB	Share
TLX	App 3Y Change in Director Interests - M McDonald		07/03/25	263.54KB	Share
TLX	App 3Y Change in Director Interests - T Olson		06/03/25	216.06KB	Share
TLX	App 3Y Change in Director Interests - HK McCann		05/03/25	241.24KB	Share
TLX	Telix Investor Webinar -Tx Urology Showcase and Expert Forum		04/03/25	141.82KB	Share
TLX	App 3X Initial Director Interests - M McDonald		03/03/25	223.51KB	Share
TLX	App 3Y Change in Director Interests - C Behrenbruch		27/02/25	280.44KB	Share
TLX	Completion of Sale of Shares by Telix CEO		27/02/25	134.45KB	Share
TLX	Notice of Pending Sale of Shares by Telix CEO		26/02/25	132.74KB	Share
TLX	FDA accepts BLA and grants priority review for Zircaix	PRICE SENSITIVE	26/02/25	144.06KB	Share
TLX	Telix Announces Board Renewal		26/02/25	142.24KB	Share
TLX	Telix Announces Change in Reporting Currency to USD	PRICE SENSITIVE	25/02/25	125.7KB	Share
TLX	Appendix 4G and 2024 Corporate Governance Statement		20/02/25	4.56MB	Share
TLX	2024 Full Year Results Presentation	PRICE SENSITIVE	20/02/25	3.06MB	Share
TLX	2024 Full Year Results Announcement	PRICE SENSITIVE	20/02/25	105.06KB	Share
TLX	Appendix 4E and 2024 Annual Report	PRICE SENSITIVE	20/02/25	14.51MB	Share
TLX	Illuccix Approved in the United Kingdom	PRICE SENSITIVE	13/02/25	176.04KB	Share
TLX	Telix 2024 Full Year Results and Investor Webcast/Call		11/02/25	135KB	Share
TLX	Cleansing Notice		31/01/25	113.99KB	Share
TLX	Application for quotation of securities - TLX		31/01/25	16KB	Share
TLX	Notification regarding unquoted securities - TLX		31/01/25	18.29KB	Share
TLX	Cleansing Notice		31/01/25	113KB	Share
TLX	Application for quotation of securities - TLX		31/01/25	16.3KB	Share
TLX	Telix Completes Acquisition of Tx Assets, Biologics Platform	PRICE SENSITIVE	31/01/25	151.14KB	Share
TLX	Telix Completes Acquisition of RLS (USA) Inc	PRICE SENSITIVE	28/01/25	144.23KB	Share
TLX	Illuccix Receives European Approval	PRICE SENSITIVE	17/01/25	149.34KB	Share
TLX	Telix JP Morgan Healthcare Conference 2025 Presentation	PRICE SENSITIVE	13/01/25	4.03MB	Share
TLX	Telix Exceeds FY24 Guidance with US$142M Q4 Revenue	PRICE SENSITIVE	13/01/25	166.97KB	Share
TLX	Proposed issue of securities - TLX		13/01/25	19.54KB	Share
TLX	Presentation to Accompany Biologics Platform Acquisition	PRICE SENSITIVE	13/01/25	883.41KB	Share
TLX	TLX to Acquire Next-Gen Therapeutics and Biologics Platform	PRICE SENSITIVE	13/01/25	216.73KB	Share
TLX	Notification of cessation of securities - TLX		09/01/25	13.52KB	Share
TLX	Managing Director and Group CEO Remuneration Update		30/12/24	139.19KB	Share
TLX	Telix Files TLX250-CDx (Zircaix) BLA for Kidney Imaging		30/12/24	139.57KB	Share
TLX	Securities Dealing Policy - Updated		13/12/24	260.39KB	Share
TLX	Notification regarding unquoted securities - TLX		28/11/24	24.31KB	Share
TLX	Application for quotation of securities - TLX		28/11/24	15.88KB	Share
TLX	Presentation to Accompany FAP-Targeting Acquisition	PRICE SENSITIVE	19/11/24	1.33MB	Share
TLX	Telix Adds FAP-Targeting Theranostic Candidates to Pipeline	PRICE SENSITIVE	19/11/24	140.37KB	Share
TLX	Securities Dealing Policy - Updated		14/11/24	256.48KB	Share
TLX	Telix ADSs Commence Trading on Nasdaq		14/11/24	123.08KB	Share
TLX	CMS payment improvement decision for radiopharma diagnostics	PRICE SENSITIVE	04/11/24	143.55KB	Share
TLX	FDA accepts NDA and grants priority review for Pixclara	PRICE SENSITIVE	24/10/24	148.42KB	Share
TLX	Pending Release of Shares from Voluntary Escrow		23/10/24	138.97KB	Share
TLX	Telix Files Form 20-F Registration Statement for Nasdaq ADS	PRICE SENSITIVE	18/10/24	171.46KB	Share
TLX	Appendix 3Z Final Director Notice (A Kluge)		17/10/24	227.35KB	Share

TLX Historical Financials in USD and H12025 OPEX (Unaudited)
05/08/25	PRICE SENSITIVE	473.82KB	Share
TLX Telix H1 2025 Results - Investor Webcast Notification
30/07/25		189.18KB	Share
TLX Pending Release of Shares from Voluntary Escrow
23/07/25		195.92KB	Share
TLX Telix Reports US$204M Q2 Revenue, Up 63% YOY
22/07/25	PRICE SENSITIVE	282.97KB	Share
TLX Gozellix Receives Permanent HCPCS Code
09/07/25	PRICE SENSITIVE	195.59KB	Share
TLX Application for quotation of securities - TLX
09/07/25		18.9KB	Share
TLX Notification of cessation of securities - TLX
09/07/25		14.32KB	Share
TLX Application for quotation of securities - TLX
20/06/25		22.03KB	Share
TLX App 3Y - Change in Director Interests - C Behrenbruch
18/06/25		324.58KB	Share
TLX Notification regarding unquoted securities - TLX
18/06/25		20.67KB	Share
TLX Telix Investor Day Presentation
11/06/25	PRICE SENSITIVE	7.51MB	Share
TLX Notification regarding unquoted securities - TLX
05/06/25		15.2KB	Share
TLX Application for quotation of securities - TLX
05/06/25		21.92KB	Share
TLX Notification regarding unquoted securities - TLX
05/06/25		26.28KB	Share
TLX Notification regarding unquoted securities - TLX
05/06/25		21.01KB	Share
TLX App 3Z Final Director Interests - K McCann
22/05/25		182.21KB	Share
TLX Telix Results of Annual General Meeting
21/05/25		230.02KB	Share
TLX Telix Annual General Meeting Presentation
21/05/25		1.53MB	Share
TLX Telix Annual General Meeting Chairman and CEO Addresses
21/05/25		236.93KB	Share
TLX Pending Release of Shares from Voluntary Escrow
19/05/25		136.4KB	Share
TLX Application for quotation of securities - TLX
16/05/25		19.37KB	Share
TLX Notification regarding unquoted securities - TLX
16/05/25		18.58KB	Share
TLX Notification of cessation of securities - TLX
16/05/25		13KB	Share
TLX Notification regarding unquoted securities - TLX
09/05/25		16.43KB	Share
TLX Cleansing Notice
06/05/25		114.02KB	Share
TLX Application for quotation of securities - TLX
06/05/25		15.97KB	Share
TLX App 3Z Final Director Interests - A Whitaker
01/05/25		181.61KB	Share
TLX Anne Whitaker Board Resignation
29/04/25		126.07KB	Share
TLX Telix Provides Regulatory Update on TLX101-CDx
28/04/25	PRICE SENSITIVE	140.77KB	Share
TLX Pending Release of Shares from Voluntary Escrow
24/04/25		139.61KB	Share
TLX Telix Reports US$186M Q1 Revenue, Up 62% YOY
22/04/25	PRICE SENSITIVE	214.9KB	Share
TLX Pending Release of Shares from Voluntary Escrow
22/04/25		137.47KB	Share
TLX Telix Notice of AGM, Proxy Form and Online Guide
17/04/25		3.33MB	Share
TLX IPAX-Linz Promising Efficacy for TLX101 Glioma Tx Candidate
16/04/25		152.97KB	Share
TLX Change of Registry Address Notification
14/04/25		67.5KB	Share
TLX Telix Responds to Recent U.S. Government Actions
07/04/25		140.09KB	Share
TLX App 3X Initial Director Interests - A Whitaker
04/04/25		230.84KB	Share
TLX Anne Whitaker Appointed as Non-Executive Director
04/04/25		129.07KB	Share
TLX Notification of cessation of securities - TLX
03/04/25		13.04KB	Share
TLX Application for quotation of securities - TLX
03/04/25		22.2KB	Share
TLX Pending Release of Shares from Voluntary Escrow
03/04/25		138.24KB	Share
TLX Pending Release of Shares from Voluntary Escrow
03/04/25		137.35KB	Share
TLX Change in substantial holding
02/04/25		467.97KB	Share
TLX Pending Release of Shares from Voluntary Escrow
02/04/25		139.99KB	Share
TLX Pending Release of Shares from Voluntary Escrow
25/03/25		136.43KB	Share
TLX Application for quotation of securities - TLX
21/03/25		21.87KB	Share
TLX FDA Approves New Prostate Cancer Imaging Agent Gozellix
21/03/25	PRICE SENSITIVE	144.27KB	Share
TLX Illuccix Approved in Brazil - 1st PSMA-PET Approval in LATAM
18/03/25		189.55KB	Share
TLX Cleansing Notice
17/03/25		112.99KB	Share
TLX Application for quotation of securities - TLX
17/03/25		17.18KB	Share
TLX Cleansing Notice
17/03/25		113.99KB	Share
TLX Application for quotation of securities - TLX
17/03/25		15.98KB	Share
TLX Notification of cessation of securities - TLX
12/03/25		13.69KB	Share
TLX App 3Y Change of Director Interests - C Behrenbruch
12/03/25		280.44KB	Share
TLX Telix Completes FAP-Targeting Theranostic Acquisition
12/03/25	PRICE SENSITIVE	135.5KB	Share
TLX App 3Y Change in Director Interests - M McDonald
07/03/25		263.54KB	Share
TLX App 3Y Change in Director Interests - T Olson
06/03/25		216.06KB	Share
TLX App 3Y Change in Director Interests - HK McCann
05/03/25		241.24KB	Share
TLX Telix Investor Webinar -Tx Urology Showcase and Expert Forum
04/03/25		141.82KB	Share
TLX App 3X Initial Director Interests - M McDonald
03/03/25		223.51KB	Share
TLX App 3Y Change in Director Interests - C Behrenbruch
27/02/25		280.44KB	Share
TLX Completion of Sale of Shares by Telix CEO
27/02/25		134.45KB	Share
TLX Notice of Pending Sale of Shares by Telix CEO
26/02/25		132.74KB	Share
TLX FDA accepts BLA and grants priority review for Zircaix
26/02/25	PRICE SENSITIVE	144.06KB	Share
TLX Telix Announces Board Renewal
26/02/25		142.24KB	Share
TLX Telix Announces Change in Reporting Currency to USD
25/02/25	PRICE SENSITIVE	125.7KB	Share
TLX Appendix 4G and 2024 Corporate Governance Statement
20/02/25		4.56MB	Share
TLX 2024 Full Year Results Presentation
20/02/25	PRICE SENSITIVE	3.06MB	Share
TLX 2024 Full Year Results Announcement
20/02/25	PRICE SENSITIVE	105.06KB	Share
TLX Appendix 4E and 2024 Annual Report
20/02/25	PRICE SENSITIVE	14.51MB	Share
TLX Illuccix Approved in the United Kingdom
13/02/25	PRICE SENSITIVE	176.04KB	Share
TLX Telix 2024 Full Year Results and Investor Webcast/Call
11/02/25		135KB	Share
TLX Cleansing Notice
31/01/25		113.99KB	Share
TLX Application for quotation of securities - TLX
31/01/25		16KB	Share
TLX Notification regarding unquoted securities - TLX
31/01/25		18.29KB	Share
TLX Cleansing Notice
31/01/25		113KB	Share
TLX Application for quotation of securities - TLX
31/01/25		16.3KB	Share
TLX Telix Completes Acquisition of Tx Assets, Biologics Platform
31/01/25	PRICE SENSITIVE	151.14KB	Share
TLX Telix Completes Acquisition of RLS (USA) Inc
28/01/25	PRICE SENSITIVE	144.23KB	Share
TLX Illuccix Receives European Approval
17/01/25	PRICE SENSITIVE	149.34KB	Share
TLX Telix JP Morgan Healthcare Conference 2025 Presentation
13/01/25	PRICE SENSITIVE	4.03MB	Share
TLX Telix Exceeds FY24 Guidance with US$142M Q4 Revenue
13/01/25	PRICE SENSITIVE	166.97KB	Share
TLX Proposed issue of securities - TLX
13/01/25		19.54KB	Share
TLX Presentation to Accompany Biologics Platform Acquisition
13/01/25	PRICE SENSITIVE	883.41KB	Share
TLX TLX to Acquire Next-Gen Therapeutics and Biologics Platform
13/01/25	PRICE SENSITIVE	216.73KB	Share
TLX Notification of cessation of securities - TLX
09/01/25		13.52KB	Share
TLX Managing Director and Group CEO Remuneration Update
30/12/24		139.19KB	Share
TLX Telix Files TLX250-CDx (Zircaix) BLA for Kidney Imaging
30/12/24		139.57KB	Share
TLX Securities Dealing Policy - Updated
13/12/24		260.39KB	Share
TLX Notification regarding unquoted securities - TLX
28/11/24		24.31KB	Share
TLX Application for quotation of securities - TLX
28/11/24		15.88KB	Share
TLX Presentation to Accompany FAP-Targeting Acquisition
19/11/24	PRICE SENSITIVE	1.33MB	Share
TLX Telix Adds FAP-Targeting Theranostic Candidates to Pipeline
19/11/24	PRICE SENSITIVE	140.37KB	Share
TLX Securities Dealing Policy - Updated
14/11/24		256.48KB	Share
TLX Telix ADSs Commence Trading on Nasdaq
14/11/24		123.08KB	Share
TLX CMS payment improvement decision for radiopharma diagnostics
04/11/24	PRICE SENSITIVE	143.55KB	Share
TLX FDA accepts NDA and grants priority review for Pixclara
24/10/24	PRICE SENSITIVE	148.42KB	Share
TLX Pending Release of Shares from Voluntary Escrow
23/10/24		138.97KB	Share
TLX Telix Files Form 20-F Registration Statement for Nasdaq ADS
18/10/24	PRICE SENSITIVE	171.46KB	Share
TLX Appendix 3Z Final Director Notice (A Kluge)
17/10/24		227.35KB	Share

REFRESH

1 2 3 4 5 6

Add to My Watchlist

What is My Watchlist?

A personalised tool to help users track selected stocks. Delivering real-time notifications on price updates, announcements, and performance stats on each to help make informed investment decisions.

(20min delay)
Last $17.64		Change -0.560(3.08%)		Mkt cap ! $5.969B

Open	High	Low	Value	Volume
$18.04	$18.04	$17.37	$63.83M	3.628M

Buyers (Bids)

No.	Vol.	Price($)
1	17	$17.64

Sellers (Offers)

Price($)	Vol.	No.
$17.66	100	1

View Market Depth

No.	Vol.	Price($)
1	17	17.640
1	1000	17.600
1	19	17.560
1	100	17.540
9	2069	17.500

Price($)	Vol.	No.
17.750	460	1
17.770	400	1
17.800	2030	2
17.830	509	1
17.850	559	2

Last trade - 16.18pm 08/08/2025 (20 minute delay)

TLX (ASX) Chart

TELIX PHARMACEUTICALS LIMITED - Announcements

Announcements

Buyers (Bids)

Sellers (Offers)

Top Stories